CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (AMEX: IDP) today announced that Robert Karr, M.D., President of Idera, will discuss the Company’s Toll-Like Receptor - targeted drug discovery and development programs and provide a general corporate overview at the BIO InvestorForum 2007 taking place October 9-11, 2007, at the Palace Hotel in San Francisco, CA. The presentation will begin at 10:30 a.m. PDT (1:30 p.m. EDT) on Thursday, October 11. The corporate presentation will be available via live audio webcast on the Company’s website at www.iderapharma.com. Archived replays will also be located on the Company’s site following the event.
